ARTICLE | Clinical News
Magneceutical Therapy: Phase II started
January 3, 2011 8:00 AM UTC
Pico-Tesla began a double-blind, placebo-controlled, U.S. Phase II trial to evaluate its Magneceutical Therapy given 4 times weekly for 2 weeks in 30 patients. ...